BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/27/2021 7:14:11 AM | Browse: 539 | Download: 1362
 |
Received |
|
2021-02-23 16:23 |
|
Peer-Review Started |
|
2021-02-23 16:30 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-14 04:28 |
|
Revised |
|
2021-06-28 14:25 |
|
Second Decision |
|
2021-09-17 03:30 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-09-19 08:50 |
|
Articles in Press |
|
2021-09-19 08:50 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-10-18 01:40 |
|
Publish the Manuscript Online |
|
2021-10-27 07:14 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Understanding the immune response and the current landscape of immunotherapy in pancreatic cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Lorena Ostios-Garcia, Julia Villamayor, Esther Garcia-Lorenzo, David Vinal and Jaime Feliu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Instituto de Salud Carlos III, Ministerio de Economia, Industria y Competitividad |
PI18/01604 |
|
| Corresponding Author |
Jaime Feliu, MD, PhD, Associate Professor, Chief Physician, Department of Oncology, La Paz University Hospital, IDIPAZ, CIBERONC, Cátedra UAM-AMGEN, Paseo de la Castellana, 261, Madrid 28046, Spain. jaimefeliu@hotmail.com |
| Key Words |
Pancreatic cancer; Immunity; Immune evasion; Tumor microenvironment; Immunotherapy; Cancer vaccines |
| Core Tip |
Immunotherapy has demonstrated effectiveness in treating several solid tumors and has become a major revolution in oncology. In pancreatic ductal adenocarcinoma, however, the outcomes continue to be poor due to its special immune response and microenvironmental characteristics. In this review, we summarize the most important concepts of the immune system and the current landscape of immunotherapy in pancreatic cancer. |
| Publish Date |
2021-10-27 07:14 |
| Citation |
Ostios-Garcia L, Villamayor J, Garcia-Lorenzo E, Vinal D, Feliu J. Understanding the immune response and the current landscape of immunotherapy in pancreatic cancer. World J Gastroenterol 2021; 27(40): 6775-6793 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i40/6775.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i40.6775 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
